Introduction The development of targeted oncology therapies relies on the availability of high-quality pharmaceutical intermediates. One such important compound is (E)-N'-(2-cyano-4-nitrophenyl)-N,N-dimethylformimidamide (CAS No. 39263-34-8). This co...
palbociclib-intermediates.hashnode.dev2 min read
No responses yet.